美股市场个股详情
BSX 波士顿科学
- 74.540
- +1.050+1.43%
交易中 05/15 11:09 (美东)
1095.87亿总市值62.64市盈率TTM
74.671最高价73.860最低价110.11万股成交量73.910今开73.490昨收8192.38万成交额0.08%换手率69.66市盈率(静)14.70亿总股本74.67152周最高5.50市净率1092.20亿流通值48.35052周最低--股息TTM14.65亿流通股74.671历史最高--股息率TTM1.10%振幅4.790历史最低74.402平均价1股每手
波士顿科学股票讨论区
登录发表评论
专栏Options Market Statistics: Tesla Stock Jumps on Accelerated Production Plans Despite Earnings Miss
News Highlights
$特斯拉(TSLA.US$ shares rose by 1.85%, closing at $144.68. Its options trading volume was 1.75 million. Call contracts account for 44.8% of the total trading volume. The most traded calls are contracts of $160 strike price that expire on Apr. 26th. The total volume reaches 48,736 with an open interest of 28,774. The most traded puts are contracts of a $140 strike price that expires o...
$特斯拉(TSLA.US$ shares rose by 1.85%, closing at $144.68. Its options trading volume was 1.75 million. Call contracts account for 44.8% of the total trading volume. The most traded calls are contracts of $160 strike price that expire on Apr. 26th. The total volume reaches 48,736 with an open interest of 28,774. The most traded puts are contracts of a $140 strike price that expires o...
24
3
Insiders selling Boston Scientific shares, even below current price, is discouraging. Yet, high insider ownership could imply company's interest in all shareholders.
1
Boston Scientific's high P/E ratio is attributed to investors' optimism about its strong future growth and market outperformance. Shareholders' confidence in the company's future earnings supports the current P/E ratio and share price.
1
Boston Scientific's EPS growth and insider ownership hint at future success, but investors should note the 2 warning signs. Its strong performance makes it a company to watch.
Piper Sandler analysts find Boston Scientific, Expedia Group, Progressive Corporation, Skechers U.S.A., Synovus Financial, and Zoetis Inc. stocks attractive due to their individual strengths and positive trends.
Meghan Scanlon from Boston Scientific forecasts merger to enhance support for urologists handling chronic conditions. Acquisition may improve earnings per share over time, though GAAP earnings may see lesser increase due to related expenses.
Morning Movers
Gapping up
$Fisker(FSR.US$ Shares of the electric vehicle company popped 9.3% after Fisker said that it grew deliveries by over 300% between the third and fourth quarter, helped by strong demand for the company’s Ocean SUV. Fisker said it intends to announce a plan in January to continue accelerating sales and deliveries.
$英伟达(NVDA.US$ Nvidia shares ticked 0.3% higher after the chipmaker announced the launc...
Gapping up
$Fisker(FSR.US$ Shares of the electric vehicle company popped 9.3% after Fisker said that it grew deliveries by over 300% between the third and fourth quarter, helped by strong demand for the company’s Ocean SUV. Fisker said it intends to announce a plan in January to continue accelerating sales and deliveries.
$英伟达(NVDA.US$ Nvidia shares ticked 0.3% higher after the chipmaker announced the launc...
22
Baird analysts anticipate Insulet's earnings to grow faster than their annual sales of approx. 20%. DexCom's margins predicted to expand with sales growth over 20% annually before GLP-1s impact. Boston Scientific considered a top-level medtech enterprise by Baird's Rescott.
Insiders selling Boston Scientific shares, even below current price, flags unsettling sentiment over company valuation. Absence of insider buying in last year doesn't instill confidence, insider buying would bolster it.
暂无评论
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
104575863 : hai
103625245 : hai guys
74049856 : someone please close my account